Atlas Trials

Recurrent Kidney Wilms Tumor

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Kidney Wilms Tumor

RecordFirmDate
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor (NCT04616560)National Cancer Institute (NCI)2021-03-08
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT (NCT04322318)Children's Oncology Group2020-10-19
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial (NCT04284774)National Cancer Institute (NCI)2020-10-13
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) (NCT03526250)National Cancer Institute (NCI)2018-08-13
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) (NCT03213704)National Cancer Institute (NCI)2017-08-23
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592)National Cancer Institute (NCI)2017-05-18

Track Recurrent Kidney Wilms Tumor automatically

Every clearance here is in the API, with alerts when new ones post.